Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FIERE D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 95 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ascioglu, S; Rex, JH; de Pauw, B; Bennett, JE; Bille, J; Crokaert, F; Denning, DW; Donnelly, JP; Edwards, JE; Erjavec, Z; Fiere, D; Lortholary, O; Maertens, J; Meis, JF; Patterson, TF; Ritter, J; Selleslag, D; Shah, PM; Stevens, DA; Walsh, TJ
      Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus

      CLINICAL INFECTIOUS DISEASES
    2. Voog, E; Le, QL; Philip, I; Benetaib, B; Michallet, M; Fiere, D; Thomas, X
      Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone

      ANNALS OF HEMATOLOGY
    3. Colita, A; Belhabri, A; Chelghoum, Y; Charrin, C; Fiere, D; Thomas, X
      Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases

      ANNALS OF ONCOLOGY
    4. Thomas, X; Olteanu, N; Charrin, C; Lheritier, VR; Magaud, JP; Fiere, D
      Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience

      AMERICAN JOURNAL OF HEMATOLOGY
    5. Thomas, X; Charrin, C; Magaud, JP; Fiere, D
      CD10 expression in T-lineage adult acute lymphoblastic leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    6. Fiere, D; Vernant, JP; Michallet, M; Degos, L; Leblond, V; Olteanu, N; Boucheix, C; Charrin, C; Varet, B; Huguet, FR; Delannoy, A; Gratecos, N; Lepage, E; Sebban, C
      Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    7. Thomas, X; Bouheddou, N; Fiere, D
      High-dose cytarabine combined to mitoxantrone in the treatment of refractory and relapsed acute lymphoblastic leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    8. Thiebaut, A; Vernant, JP; Degos, L; Huguet, FR; Reiffers, J; Sebban, C; Lepage, E; Thomas, X; Fiere, D
      Adult acute lymphocytic leukemia study testing chemotherapy and autologousand allogeneic transplantation - A follow-up report of the French protocolLALA 87

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    9. Michallet, M; Thiebaut, A; Philip, I; Charrin, C; Vigouroux, C; Thomas, X; Bilger, K; Belhabri, A; Guyotat, D; Corront, B; Salles, B; Dumontet, C; Peaud, PY; Vilque, JP; Devidas, A; Fiere, D
      Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha

      LEUKEMIA
    10. Thomas, X; Troncy, J; Belhabri, A; Thiebaut, A; Bouheddou, N; Michallet, M; Fleurette, J; Pivot, C; Fiere, D; Archimbaud, E
      A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia

      PRESSE MEDICALE
    11. Michallet, M; Philip, T; Philip, I; Godinot, H; Sebban, C; Salles, G; Thiebaut, A; Biron, P; Lopez, F; Mazars, P; Roubi, N; Leemhuis, T; Hanania, E; Reading, C; Fine, G; Atkinson, K; Juttner, C; Coiffier, B; Fiere, D; Archimbaud, E
      Transplantation with selected autologous peripheral blood CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution

      EXPERIMENTAL HEMATOLOGY
    12. Gorin, NC; Labopin, M; Pichard, P; Sierra, J; Fiere, D; Rio, B; Meloni, G; Sanz, MA; Iriondo, A; Fouillard, L; Frassoni, F
      Feasibility and recent improvement of autologous stem cell transplantationfor acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Thomas, X; Teillon, MH; Belhabri, A; Rimokh, R; Fiere, D; Magaud, JP; Archimbaud, E
      Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission

      HEMATOLOGY AND CELL THERAPY
    14. Belhabri, A; Thomas, X; Troncy, J; Assouline, D; Michallet, M; Wattel, E; Tigaud, JD; Blanc, M; Fiere, D; Archimbaud, E
      Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study

      LEUKEMIA & LYMPHOMA
    15. Michallet, M; Perrin, MC; Belhabri, A; Molina, L; Nicolini, F; Tigaud, JD; Sotto, JJ; Guyotat, D; Fiere, D; Archimbaud, E
      Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    16. THOMAS X; THIEBAUT A; OLTEANU N; DANAILA C; CHARRIN C; ARCHIMBAUD E; FIERE D
      PHILADELPHIA-CHROMOSOME-POSITIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA -CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME

      HEMATOLOGY AND CELL THERAPY
    17. THOMAS X; ANGLARET B; ADELEINE P; MARITAZ O; BAILLY M; FIERE D; ARCHIMBAUD E
      INFLUENCE OF MALIGNANT-CELL CLONOGENIC CAPACITIES AND POSITION ALONG THE MATURATION PATHWAY ON THEIR SUSCEPTIBILITY TO LYMPHOKINE-ACTIVATEDKILLER-CELL CYTOTOXICITY

      Leukemia & lymphoma
    18. Fiere, D
      Eric Archimbaud - Necrology

      ANNALS OF HEMATOLOGY
    19. THOMAS X; FIERE D; ARCHIMBAUD E
      INFLUENCE OF INCREASED BODY-MASS INDEX ON DRUG TOXICITY IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    20. ARCHIMBAUD E; CHARRIN C; MAGAUD JP; CAMPOS L; THOMAS X; FIERE D; RIMOKH R
      CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ADULT DE-NOVO AND SECONDARY ACUTE MYELOID-LEUKEMIA WITH BALANCED 11Q23 CHROMOSOMAL ANOMALY OR MLL GENE REARRANGEMENT COMPARED TO CASES WITH UNBALANCED 11Q23 ANOMALY -CONFIRMATION OF THE EXISTENCE OF DIFFERENT ENTITIES WITH 11Q23 BREAKPOINT

      Leukemia
    21. MICHALLET M; FIERE D
      IN MEMORY OF ARCHIMBAUD,ERIC

      Bone marrow transplantation
    22. MICHALLET M; PERSAT F; KRANZHOFER N; LEVRON JC; PRAT C; BELHABRI A; CHWETZOFF E; LEMOING JP; FIERE D; PIENS MA
      PHARMACOKINETICS OF ITRACONAZOLE ORAL SOLUTION IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS RECEIVING TOTAL-BODY IRRADIATION

      Bone marrow transplantation
    23. BELHABRI A; MICHALLET M; THIEBAUT A; PHILIP I; CHARRIN C; FIERE D; ARCHIMBAUD E
      AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) WITH PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IFN)

      Bone marrow transplantation
    24. BILHOUNABERA C; MACINTYRE E; CAYUELA JM; FRENOY N; BORIES D; BASTARD C; DESCHASEAUX M; DAVI F; MARTIAT P; DUPONT M; RAYNAUD S; HAYETTE S; CHARRIN C; BARDOU MJ; FIERE D; GABERT J
      PROSPECTIVE MULTICENTRIC MOLECULAR STUDY FOR POOR-PROGNOSIS FUSION TRANSCRIPTS AT DIAGNOSIS IN ADULT ALL PATIENTS - AN UPDATE OF THE LALA94TRIAL

      British Journal of Haematology
    25. DOMBRET H; THOMAS X; BLAISE D; HUGUET F; BOIRON JM; BUZYN A; STAMATOULAS A; DELANNOY A; BRADSTOCK K; BOUCHEIX C; CHARRIN C; GABERT J; LEBBE G; LHERITIER V; FIERE D
      INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/

      British Journal of Haematology
    26. FIERE D; SEBBAN C; BOIRON JP; VERNANT JP; HUGUET FR; MICLEA JP; SUTTON C; CAHN JY; DREYFUS F; LEPAGE E
      COMPARISON OF ALLOGENIC TRANSPLANTATION, AUTOLOGOUS TRANSPLANTATION AND CHEMOTHERAPY AS POST INDUCTION TREATMENT IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - LONG-TERM REPORT OF THE FRENCH GROUP OF TREATMENT OF ADULT ALL (LALA-87 PROTOCOL)

      British Journal of Haematology
    27. THOMAS X; HIRSCHAUER C; TRONCY J; ASSOULINE D; JOLY MO; FIERE D; ARCHIMBAUD E
      SERUM INTERLEUKIN-6 LEVELS IN ADULT ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP WITH DISEASE CHARACTERISTICS AND OUTCOME

      Leukemia & lymphoma
    28. THOMAS X; ANGLARET B; THIEBAUT A; BELHABRI A; TREILLERITOUET D; FIERE D; ARCHIMBAUD E
      IMPROVEMENT OF PROGNOSIS IN REFRACTORY AND RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA OVER RECENT YEARS - THE ROLE OF ALL-TRANS-RETINOIC ACID THERAPY

      Annals of hematology
    29. DELANNOY A; SEBBAN C; CONYMAKHOUL P; CAZIN B; CORDONNIER C; BOUABDALLAH R; CAHN JY; DREYFUS F; SADOUN A; VERNANT JP; GAY C; BROUSTET A; MICHAUX JL; FIERE D
      AGE-ADAPTED INDUCTION TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN THE ELDERLY AND ASSESSMENT OF MAINTENANCE WITH INTERFERON COMBINED WITH CHEMOTHERAPY - A MULTICENTRIC PROSPECTIVE-STUDY IN 40 PATIENTS

      Leukemia
    30. MOREAU P; FIERE D; BEZWODA WR; FACON T; ATTAL M; LAPORTE JP; COLOMBAT P; HAAK HL; MONCONDUIT M; LOCKHORST H; GIRAULT D; HAROUSSEAU JL
      PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR WITHOUT STEM-CELL TRANSPLANTATION AFTERHIGH-DOSE MELPHALAN IN PATIENTS WITH MULTIPLE-MYELOMA

      Journal of clinical oncology
    31. MICHALLET M; JAVAUX F; GEBUHRER L; BELHABRI A; BOUHEDDOU N; CHARRIN C; LASNE Y; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN CYTOGENETIC AND MOLECULAR STUDIES (CHIMERISM AND MINIMAL RESIDUAL DISEASE) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - INTEREST FOR STRATEGY AFTER RELAPSE POSTTRANSPLANT

      Experimental hematology
    32. ARCHIMBAUD E; MICHALLET M; PHILIP L; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    33. RINGDEN O; LABOPIN M; GLUCKMAN E; REIFFERS J; VERNANT JP; JOUET JP; HAROUSSEAU JL; FIERE D; BACIGALUPO A; FRASSONI F; GORIN NC
      STRONG ANTILEUKEMIC EFFECT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS HAVING ACUTE-LEUKEMIA TREATED WITH METHOTREXATE AND CYCLOSPORINE

      Transplantation proceedings
    34. ARCHIMBAUD E; MICHALLET M; PHILIP I; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    35. THOMAS X; THIEBAUT A; OLTEANU N; CHARRIN C; ARCHIMBAUD E; FIERE D
      PHILADELPHIA-CHROMOSOME-POSITIVE (PH-LEUKEMIA (ALL) - CLINICAL AND CYTOGENETIC CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME() ADULT ACUTE LYMPHOBLASTIC)

      Blood
    36. FIERE D; BOUABDALLAH R; RIGALHUGUET F; CAZIN B; VERNANT JP; PIERRE P; DELANNOY A
      ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN THE ELDERLY - A FEASIBILITY STUDY OF TREATMENT WITH INTERFERON-ALPHA-2B (IFN) AFTER INDUCTION AND CONSOLIDATION THERAPY

      Blood
    37. THIEBAUT A; ANGLARET B; THOMAS X; LE QH; CHABERT C; BELHABRI A; FIERE D; ARCHIMBAUD E
      IMPACT OF PREINDUCTION THERAPY LEUKAPHERESIS ON TREATMENT OUTCOME IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML) PRESENTING WITH HYPERLEUKOCYTOSIS

      Blood
    38. AGAPE P; MAHON FX; MARIT G; BOURQUARD P; CARMELO D; CHRISTIAN B; FIERE D; JOUET JP; LEPEU G; MOREAU P; POLLET JP; REMENEIRAS L; COUSIN T; REIFFERS J
      ALL-TRANS-RETINOIC ACID COMBINED WITH INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA - RESULTS OF A PILOT-STUDY

      Blood
    39. GERHARTZ HH; ZWIERZINA H; SUCIU S; WALTHER J; DARDENNE M; NEUWIRTOVA R; FENAUX P; BEKSAC M; HAROUSSEAU JL; LOUWAGIE A; THYSS A; FIERE D; COIFFIER B; BAUMELOU F; LABAR B; SOLBU G; WILLEMZE R
      RANDOMIZED 3-ARM PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/

      Blood
    40. STRYCKMANS P; SUCIU S; ANNINO L; SAGLIO G; MUUS P; MARIE JP; DOMBRET H; GAMBERT J; SOLBU G; DARDENNE M; MANDELLI F; FIERE D
      MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC)

      Blood
    41. GABERT J; BILHOUNABERA C; MACINTYRE E; CAYUELA JM; FRENOY N; BORIES D; BASTARD C; DESCHASEAUX M; DAVI F; MARTIAT P; DUPONT M; RAYNAUD S; HAYETTE S; CHARRIN C; FIERE D
      PROSPECTIVE MULTICENTRIC MOLECULAR STUDY FOR POOR-PROGNOSIS FUSION TRANSCRIPTS AT DIAGNOSIS IN ADULT ALL PATIENTS - AN UPDATE OF THE LALA94TRIAL

      Blood
    42. VEY N; BLAISE D; TIBERGHIEN P; ATTAL M; PICO JL; REIFFERS J; HARROUSSEAU JL; FIERE D; TABILIO A; GABUS R; BRANDELY M; MARANINCHI D
      A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMAS

      Leukemia & lymphoma
    43. THOMAS X; ANGLARET B; TREILLERITOUET D; BASTION Y; FIERE D; ARCHIMBAUD E
      OCCURRENCE OF T-CELL LYMPHOMA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    44. RAYNAUD S; MAUVIEUX L; CAYUELA JM; BASTARD C; BILHOUNABERA C; DEBUIRE B; BORIES D; BOUCHEIX C; CHARRIN C; FIERE D; GABERT J
      TEL AML1 FUSION GENE IS A RARE EVENT IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Leukemia
    45. CAMPOS L; SABIDO O; SEBBAN C; CHARRIN C; BERTHEAS MF; FIERE D; GUYOTAT D
      EXPRESSION OF BCL-2 PROTOONCOGENE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    46. THOMAS X; ANGLARET B; MARITAZ O; BAILLY M; FIERE D; ARCHIMBAUD E
      MODULATION OF CELL SENSITIVITY TO LYMPHOKINE-ACTIVATED KILLER (LAK) CYTOLYSIS - ROLE OF CYTOKINES AND DIFFERENTIATING AGENTS

      Experimental hematology
    47. ANGLARET B; THOMAS X; MOULLET I; BAILLY M; MARITAZ O; FIERE D; ARCHIMBAUD E
      DIFFERENTIAL ADHESIVENESS ON PURIFIED SUPPORTS BETWEEN BLOOD AND MARROW LEUKEMIC-CELLS HAVING SIMILAR PATTERN OF VLA ADHESION MOLECULES EXPRESSION

      Experimental hematology
    48. RINGDEN O; LABOPIN M; GLUCKMAN E; REIFFERS J; VERNANT JP; JOUET JP; HARROUSSEAU JL; FIERE D; BACIGALUPO A; FRASSONI F; GORIN NC
      GRAFT-VERSUS-LEUKEMIA EFFECT IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS WITH ACUTE-LEUKEMIA IS MAINTAINED USING CYCLOSPORINE-A COMBINED WITH METHOTREXATE AS PROPHYLAXIS

      Bone marrow transplantation
    49. GUILHOT F; GUERCI A; FIERE D; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; ROCHANT H; NAJMAN A; NICOLINI F; COLOMBAT P; ABGRALL JF; IFRAH N; BRIERE J; BAUTERS F; NAVARRO M; MORICE P; BORDESSOULE D; VILQUE JP; DESABLENS B; TERTIAN G; BLANC M; CHASTANG C; TANZER J
      THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS

      Bone marrow transplantation
    50. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; AMOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; BARANGER L; BOASSON M; IFRAH N; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOLSEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POLSSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOUMILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGLER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
      CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)

      Blood
    51. GABERT J; BILHOUNABERA C; MACINTYRE E; CAYUELA JM; FRENOY N; BORIES D; BASTARD C; DESCHASEAUX M; DAVI F; MARTIAT P; DUPONT M; RAYNAUD S; CHARRIN C; FIERE D
      PROSPECTIVE MULTICENTRIC MOLECULAR STUDY FOR POOR-PROGNOSIS FUSION TRANSCRIPTS AT DIAGNOSIS IN ADULT ALL PATIENTS - LALA94 TRIAL

      Blood
    52. MICHALLET M; BELHABRI A; MOULLET I; PHILIP I; TREMISI P; CHARRIN C; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN PERIPHERAL-BLOOD STEM-CELLS (PBSC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IF) AND PBSC HARVESTED AT DIAGNOSIS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA (CML)

      Blood
    53. THIEBAUT A; SEBBAN C; VERNANT JP; THOMAS X; FIERE D
      INITIAL CENTRAL-NERVOUS-SYSTEM (CNS) INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - CHARACTERISTICS AND LONG-TERM OUTCOME

      Blood
    54. DOMBRET H; GABERT J; MACINTYRE E; CAYUELA JM; CHARRIN C; THOMAS X; STOPPA AM; VEIL A; TILLY H; REIFFERS J; ATTAL M; DELANNOY A; BOUCHEIX C; RACADOT E; MICLEA JM; BLAISE D; VERNANT JP; LHERITIER V; FIERE D
      26 PERCENT OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ENROLLED IN A MULTICENTER TRIAL HAVE BCR-ABL LEUKEMIA AND HALF OF THEMCAN RECEIVE A STEM-CELL TRANSPLANTATION (SCT)

      Blood
    55. GERHARTZ HH; WALTHER JH; NEUWIRTOVA R; FENAUX P; HAROUSSEAU JL; BEKSAC M; ZWIERZINA H; BAUMELOU E; FIERE D; LOUWAGIE A; THYSS A; DARDENNE M; SOLBU G; SUCIU S; ZITTOUN R
      RANDOMIZED-3 ARMED PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/

      Blood
    56. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; BAUDOIN F; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; ARNOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOISEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POISSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOURNILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGIER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
      CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE

      Blood
    57. NGUYEN C; MISERY L; TIGAUD JD; PETIOT A; FIERE D; FAURE M; CLAUDY A
      ALPHA-INTERFERON-INDUCED PSORIASIS

      Annales de medecine interne
    58. THOMAS X; DANAILA C; BACH QK; DUFOUR P; CHRISTIAN B; CORRONT B; BOSLY A; BASTION Y; GRATECOS N; LEBLAY R; SEBBAN C; ARCHIMBAUD E; FIERE D
      SEQUENTIAL INDUCTION CHEMOTHERAPY WITH VINCRISTINE, DAUNORUBICIN, CYCLOPHOSPHAMIDE, AND PREDNISONE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Annals of hematology
    59. THOMAS X; ARCHIMBAUD E; CHARRIN C; MAGAUD JP; FIERE D
      CD34 EXPRESSION IS ASSOCIATED WITH MAJOR ADVERSE PROGNOSTIC FACTORS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    60. MARIE JP; VEKHOFF A; CONYMAKHOUL P; FIERE D; GUY H; HERBRECHT R; MILPIED N; PICO JL; PLANTIER I
      PIPERACILLIN TAZOBACTAM PLUS AMIKACIN VER SUS CEFTAZIDIME PLUS AMIKACIN IN NEUTROPENIC PATIENTS WITH FEVER AN OPEN MULTICENTRIC TRIAL

      La Presse medicale
    61. ARCHIMBAUD E; THOMAS X; LEBLOND V; MICHALLET M; FENAUX P; CORDONNIER C; DREYFUS F; TROUSSARD X; JAUBERT J; TRAVADE P; TRONCY J; ASSOULINE D; FIERE D
      TIMED SEQUENTIAL CHEMOTHERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF THE ETOPOSIDE, MITOXANTRONE, AND CYTARABINE-86 TRIAL

      Journal of clinical oncology
    62. HOURS M; FEVOTTE J; AYZAC L; DANANCHE B; BERGERET A; MILAN JJ; BONHOMME I; FIERE D; PHILIPPE J; FABRY J
      OCCUPATIONAL EXPOSURES AND HEMATOLOGIC MA LIGNANCIES - A CASE-CONTROLSTUDY IN LYON (FRANCE)

      Revue d'epidemiologie et de sante publique
    63. SEBBAN C; BROWMAN G; GAFNI A; NORMAN G; LEVINE M; ASSOULINE D; FIERE D
      DESIGN AND VALIDATION OF A BEDSIDE DECISION INSTRUMENT TO ELICIT A PATIENTS PREFERENCE CONCERNING ALLOGENIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      American journal of hematology
    64. ASSOULINE D; NEGRIER C; COQUARD I; ARCHIMBAUD E; FIERE D; BRET M; BODNAR D
      SUCCESSFUL SYSTEMIC THROMBOLYSIS OF HEPATIC VEIN-THROMBOSIS IN A PATIENT WITH PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID

      American journal of hematology
    65. ANGLARET B; THIEBAUT A; THOMAS X; MICHALLET M; FIERE D; ARCHIMBAUD E
      EFFECT OF CONTINUOUS INTRAVENOUS-INFUSION OF PENTOXIFYLLINE ON REGIMEN RELATED TOXICITY IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    66. THOMAS X; CAMPOS L; ANGLARET B; SABIDO O; FIERE D; ARCHIMBAUD E
      MODIFICATIONS IN THE EXPRESSION OF ADHESION MOLECULES ON ACUTE PROMYELOCYTIC LEUKEMIA (APL) CELLS WITH IN-VITRO DIFFERENTIATION

      Experimental hematology
    67. ARCHIMBAUD E; MICHALLET M; PHILIP I; SEBBAN C; DANAILA C; FIERE D
      G-CSF (FILGRASTIM) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA

      Experimental hematology
    68. SEBBAN C; BROWMAN GP; LEPAGE E; FIERE D
      PROGNOSTIC VALUE OF EARLY RESPONSE TO CHEMOTHERAPY ASSESSED BY THE DAY-15 BONE-MARROW ASPIRATION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PROSPECTIVE ANALYSIS OF 437 CASES AND ITS APPLICATION FOR DESIGNING INDUCTION CHEMOTHERAPY TRIALS

      Leukemia research
    69. ARCHIMBAUD E; CHARRIN C; RIMOKH R; CAMPOS L; THOMAS X; MAGAUD JP; FIERE D
      ADULT ACUTE NON LYMPHOCYTIC-LEUKEMIA (ANLL) WITH CHROMOSOME 11Q23 BREAKPOINT - A COMPARISON WITH ANLL WITH NORMAL KARYOTYPE

      Blood
    70. THOMAS X; BELHABRI A; TREILLERITOUET D; FIERE D; ARCHIMBAUD E
      ACUTE PROMYELOCYTIC LEUKEMIA (APL) - THERAPY RESULTS AND PROGNOSTIC FACTORS OVER A 23-YEAR PERIOD

      Blood
    71. MICHALLET M; MOULLET I; ARCHIMBAUD E; TARDY JC; DHEDIN N; BELHABRI A; GUYOTAT D; TIGAUD JD; AYMARD M; FIERE D
      RETROSPECTIVE STUDY OF HEPATITIS-C VIRUS-INFECTION IN 244 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANT (1980 TO 1993)

      Blood
    72. GABERT J; MACINTYRE E; RAYNAUD S; BILHOUNABERA C; DEBUIRE B; CAYUELA JM; FERRAND C; BORIES D; BASTARD C; DAVI F; MARTIAT P; DURIEUX E; FIERE D
      MOLECULAR SCREENING FOR T(9-22), T(4-11), T(1-19) AND T(12-21) TRANSLOCATIONS FOR ADULT LYMPHOID LEUKEMIAS AT DIAGNOSIS - THE EXPERIENCE OFTHE LALA MOLECULAR-BIOLOGY GROUP

      Blood
    73. GUYOTAT D; SEBBAN C; BERTHEAS MF; CHARRIN C; FIERE D; CAMPOS L
      SIGNIFICANCE OF BCL-2 PROTOONCOGENE EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS

      Blood
    74. SEBBAN C; DELANNOY A; TABAH I; CONYMAKHOUN P; CAZIN B; CORDONNIER C; BOUABDALLAH R; CAHN JY; DREYFUS F; SADOUN A; GAY C; BROUSTET A; MICHAUX JL; FIERE D
      TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN THE ELDERLY - A FEASIBILITY STUDY OF INTERFERON DURING MAINTENANCE

      Blood
    75. VEY N; BLAISE D; TIBERGHIEN P; ATTAL M; PICO JL; REIFFERS J; HARROUSSEAU JL; FIERE D; TABILIO A; GABUS R; BRANDELY M; STOPPA AM; MARANINCHI D
      A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN 25 MALIGNANT-LYMPHOMAS

      Blood
    76. RACADOT E; SEBBAN C; BOUCHEIX C; DAVID B; ATTAL M; REIFFERS J; GISSELBRECHT C; VERNANT J; TROUSSARD X; HERVE P; FIERE D
      AUTOLOGOUS BMT FOR POSTREMISSION THERAPY IN ADULT ALL - AN IMMUNOLOGICAL APPROACH

      Leukemia & lymphoma
    77. RABODONIRINA M; PIENS MA; MONIER MF; GUEHO E; FIERE D; MOJON M
      FUSARIUM INFECTIONS IN IMMUNOCOMPROMISED PATIENTS - CASE-REPORTS AND LITERATURE-REVIEW

      European journal of clinical microbiology & infectious diseases
    78. SHEN N; FFRENCH P; GUYOTAT D; FFRENCH M; FIERE D; BRYON PA; DECHAVANNE M
      EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      European journal of haematology
    79. THOMAS X; FIERE D; ARCHIMBAUD E
      PERSISTENCE OF RETINOIC ACID SENSITIVITY IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA WITH EXTRAMEDULLARY INVOLVEMENT

      Leukemia
    80. GERHARTZ HH; MARCUS R; DELMER A; ZWIERZINA H; SUCIU S; DARDENNE M; SOLBU G; DEWITTE T; JACOBS A; VISANI G; FIERE D; SONNEVELD P; LABAR B; HOFFBRAND AV; FENAUX P; HAYAT M; THYSS A; DEBUSSCHER L; COIFFIER B; SIZOO W; WILLEMZE R; RIBEIRO M; MANDELLI F; BURGHOUTS G; CAUCHIE C; PEETERMANS M; ROOZENDAAL KJ; GOUDSMIT R; DOUER D; CASTOLDI GL; STERN A; ZITTOUN R
      A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA

      Leukemia
    81. ARCHIMBAUD E; THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    82. SEBBAN C; LEPAGE E; VERNANT JP; GLUCKMAN E; ATTAL M; REIFFERS J; SUTTON L; RACADOT E; MICHALLET M; MARANINCHI D; DREYFUS F; FIERE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - A COMPARATIVE-STUDY

      Journal of clinical oncology
    83. PRENTICE HG; GLUCKMAN E; POWLES RL; LJUNGMAN P; MILPIED NJ; RANADA JMF; MANDELLI F; KHO P; KENNEDY L; BELL AR; HAMON MD; COUMAR A; HIRSCH I; HANRAHAN A; BURNETT A; RUSSELL N; HUNTER A; CAHN JY; FLESCH M; FIERE D; TIGAUD J; ASHCAN J; ARCESE W; DINUCCI G; GENTILE G; DELAURENZI A; PACILLI L; ROSSIFERRINI P; BOSI A; MARTELLI M; AVERSA F; FELICINI R; TURA S; ROSTI G; BERLARDINELLI AR; BERNASCONI C; ALLESSANDRINO E; LUCARELLI G; GALIMBERTI M; KOLB JH; CAMERA R; BEESLEY K; FIDDIAN AP; GEFFRIER C; PAPARATTI U; PARKE A; USAN L
      IMPACT OF LONG-TERM ACYCLOVIR ON CYTOMEGALOVIRUS-INFECTION AND SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Lancet
    84. BOUCHEIX C; DAVID B; SEBBAN C; RACADOT E; BENE MC; BERNARD A; CAMPOS L; JOUAULT H; SIGAUX F; LEPAGE E; HERVE P; FIERE D
      IMMUNOPHENOTYPE OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, CLINICAL-PARAMETERS, AND OUTCOME - AN ANALYSIS OF A PROSPECTIVE TRIAL INCLUDING 562 TESTED PATIENTS (LALA87)

      Blood
    85. GUILHOT F; SCHUESSLER M; RAPP MJ; HAROUSSEAU JL; FIERE D
      CYTOGENETICS RESPONSES IN CML PATIENTS TREATED WITH A DAILY ORALLY ARA-C PRODRUG YNKOI - A PHASE-I II TRIAL/

      Blood
    86. HAROUSSEAU JL; FIERE D; BEZWODA WR; FACON T; ATTAL M; LAPORTE JP; COLOMBAT P; HAAK HL; MONCONDUIT N; LOCKHORST H; GIRAULT D
      GM-CSF INSTEAD OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - RESULT OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED STUDY

      Blood
    87. FIERE D; SEBBAN C; VERNANT JP; WITZ F; RIGALHUGUET F; BOUCHEIX C; RACADOT E; PIGNON B; DELANNOY A; REIFFERS J; SUTTON L; ARCHIMBAUD E; LEPAGE E
      LONG-TERM RESULTS OF CHEMOTHERAPY, ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) AS POST REMISSION THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) FOR PATIENTS INCLUDED IN A PROSPECTIVE MULTICENTRIC TRIAL (LALA-87)

      Blood
    88. THOMAS X; CAMPOS L; SABIDO O; FIERE D; ARCHIMBAUD E
      EXPRESSION OF ADHESION MOLECULES AND ITS IN-VITRO MODIFICATIONS IN DIFFERENTIATION CULTURE WITH ALL-TRANS-RETINOIC ACID (ATRA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      Blood
    89. MICHALLET M; ARCHIMBAUD E; MOLINA L; PERRIN MC; BELHABRI A; GUYOTAT D; NICOLINI F; TIGAUD JD; HOLLARD D; FIERE D
      IMPACT OF GRAFT-VERSUS-HOST DISEASE PROPHYLACTIC AND THERAPEUTIC MANAGEMENT ON SURVIVAL AND DURATION OF COMPLETE REMISSION

      Blood
    90. KRANZHOFER N; MICHALLET M; GEBUHRER L; FREICHE JC; DHEDIN N; TIGAUD JD; LABONNE MP; ARCHIMBAUD E; FIERE D
      EVALUATION OF THE CHIMERIC STATE BY ENZYMATIC AMPLIFICATION OF VARIABLE NUMBER OF TANDEM REPEATS AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOLLOWING CONDITIONING REGIMEN CONTAINING EITHER TOTAL-BODY IRRADIATION OR BUSULFAN

      Blood
    91. ARCHIMBAUD E; THOMAS X; ASSOULINE D; WATTEL E; MICHALLER M; BELHABRI A; MURON T; TIGAUD JD; TRONCY J; SEBBAN C; FIERE D
      CONTINUOUS-INFUSION CARBOPLATIN IN ASSOCIATION TO IDARUBICIN OR MITOXANTRONE FOR HIGH-RISK ACUTE MYELOID-LEUKEMIA - A RANDOMIZED PHASE-II STUDY

      Blood
    92. FIERE D; LEPAGE E; SEBBAN C; BOUCHEIX C; GISSELBRECHT C; VERNANT JP; VARET B; BROUSTET A; CAHN JY; RIGALHUGUET F; WITZ F; MICHAUX JL; MICHALLET M; REIFFERS J
      ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A MULTICENTRIC RANDOMIZED TRIAL TESTING BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY

      Journal of clinical oncology
    93. SHEN N; FFRENCH P; VILLE D; GUYOTAT D; FFRENCH M; HANSS M; FIERE D; BRYON PA; DECHAVANNE M
      EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Thrombosis and haemostasis
    94. BELANGER C; ESPEROUBOURDEAU H; BORDIGONI P; JOUET JP; SOUILLET G; MILPIED N; TROUSSARD X; KUENTZ M; HERVE P; REIFFERS J; DEMEOCQ F; DAURIAC C; BLAISE D; MICHALLET M; FIERE D; FREYCON F; GRATECOS N; RIO B; LEBLOND V; IFRAH N; ATTAL M; BERGERAT JP; VILMER E; PICO J; RAFFOUX C; CAUDRELIER P; GLUCKMAN E
      USE OF AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY FOR GVHD PROPHYLAXIS IN UNRELATED DONOR BMT

      Bone marrow transplantation
    95. THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D; ARCHIMBAUD E
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION (BMT) IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA (AML)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:24:05